Information Provided By:
Fly News Breaks for August 26, 2015
SRPT
Aug 26, 2015 | 09:02 EDT
After the FDA set a PDUFA date of February 27 for Sarepta's eteplirsen, Roth Capital says "it would not be surprised" if the FDA grants the drug accelerated approval around December 27. The firm says it would not be surprised if the stock dropped due to a sell the news reaction. However, the firm recommends buying the shares ahead of data expected to be reported in October.
News For SRPT From the Last 2 Days
There are no results for your query SRPT